WATERS CORP /DE/ (WAT): Results of Operations and Financial Condition
WATERS CORP /DE/ (WAT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d163377dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 For Immediate Release Contact: Caspar Tudor, Head of Investor Relations – (508) 482-3448 Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results Second Quarter 2026 Highlights • Total reported revenue o
How this was made
The 30-second read
Why it matters
The key tradable update is the broad guidance raise for 2026 (organic revenue growth and adjusted EPS) plus Q3 2026 outlook, which can reprice expectations for revenue growth and earnings power.
Market read
A same-day guidance raise with quantified revenue and adjusted EPS ranges is a direct catalyst for valuation and positioning in WAT.
What to watch
The guidance includes both organic and acquired business components; traders may separate organic constant-currency growth from acquired revenue contribution and FX effects.
Background
Waters filed an SEC 8-K with Q2 2026 results and updated full-year and Q3 2026 guidance, including organic constant-currency growth and adjusted EPS targets.
Ticker impact
Waters reported Q2 2026 results and raised full-year 2026 guidance, including adjusted EPS to $14.45 to $14.65.
Moderately positive reaction expected, with follow-through tied to whether investors focus on adjusted EPS and organic growth versus GAAP dilution.
The filing discloses specific Q2 performance versus guidance and a full-year guidance increase across revenue and adjusted EPS, which are direct valuation inputs.
Market effects
Strengthening end-market conditions and raised organic growth guidance can improve sentiment for analytical instruments and consumables demand.
Limited direct regional spillover; primarily US-listed large-cap med-tech sentiment.
Global lab spending read-through via organic constant-currency growth and FX translation commentary.
Counterpoint
Investors may discount adjusted metrics and focus on GAAP EPS loss and acquisition-related purchase accounting, questioning sustainability of the guidance raise.
Key entities
- companyWaters Corporation
NYSE-listed lab instruments and diagnostics company reporting Q2 2026 results and raising full-year 2026 guidance.
- executiveUdit Batra, Ph.D.
President and CEO cited organic growth, integration momentum, and broader end-market recovery as drivers.
